Key result
CMR shows ~24-point lower diagnostic yield than TEE for PFO in stroke patients.
Why the study?
To compare the diagnostic yield of echocardiography and cardiovascular MRI to detect structural sources of embolism in patients with ischemic stroke and non-stroke populations.
Does cardiovascular MRI improve the diagnostic yield for structural cardioaortic sources of embolism compared to echocardiography in patients with acute ischemic stroke and non-stroke populations?
Meta-Analysis (n=2,525)
Yes
Does cardiovascular MRI improve the diagnostic yield for structural cardioaortic sources of embolism compared to echocardiography in patients with acute ischemic stroke and non-stroke populations?
CMR and echocardiography have similar diagnostic yields for most structural cardioaortic sources of stroke except PFO (where TEE is superior) and LV thrombus in non-stroke cohorts (where CMR is superior), though randomized diagnostic trials are needed to establish whether routine CMR alters clinical outcomes.
May guide modality selection in embolism workup; leaves open whether CMR alters clinical outcomes versus echocardiography.
Background: To compare the diagnostic yield of echocardiography and cardiovascular MRI (CMR) to detect structural sources of embolism, in patients with ischemic stroke with a secondary analysis of non-stroke populations. Methods and Results: We searched MEDLINE/Embase (from 01.01.2000 to 24.04.2021) for studies including CMR to assess prespecified sources of embolism. Comparison included transthoracic and/or transesophageal echocardiography. Two authors independently screened studies, extracted data and assessed bias using the QUADAS-2 tool. Estimates of diagnostic yield were reported and pooled. Twenty-seven studies with 2,525 patients were included in a study-level analysis. Most studies had moderate to high risk of bias. Persistent foramen ovale, complex aortic plaques, left ventricular and left atrial thrombus were the most common pathologies. There was no difference in the yield of left ventricular thrombus detection between both modalities for stroke populations (4 studies), but an increased yield of CMR in non-stroke populations (28.1 vs. 16.0%, P < 0.001, 10 studies). The diagnostic yield in stroke patients for detection of persistent foramen ovale was lower in CMR compared to transoesophageal echocardiography (29.3 vs. 53.7%, P < 0.001, 5 studies). For both echocardiography and CMR the clinical impact of the management consequences derived from many of the diagnostic findings remained undetermined in the identified studies. Conclusions: Echocardiography and CMR seem to have similar diagnostic yield for most cardioaortic sources of embolism except persistent foramen ovale and left ventricular thrombus. Randomized controlled diagnostic trials are necessary to understand the impact on the management and potential clinical benefits of the assessment of structural cardioaortic stroke sources. Registration: PROSPERO: CRD42020158787.
No takes yet. Share an insight, caveat, or question.
Meinel et al. (2021) conducted a meta-analysis in Acute ischemic stroke and non-stroke populations undergoing evaluation for cardioaortic sources of embolism (n=2,525). Cardiovascular MRI (CMR) vs. Transthoracic echocardiography (TTE) and/or transesophageal echocardiography (TEE) was evaluated on Diagnostic yield (proportion of patients with a specific prespecified pathology on CMR or echocardiography), specifically persistent foramen ovale (PFO) detection in stroke patients (p=<0.001). Cardiovascular MRI had a lower diagnostic yield than transesophageal echocardiography for persistent foramen ovale in stroke patients (29.3% vs 53.7%, P<0.001), but higher yield for LV thrombus in non-stroke patients (28.1% vs 16.0%, P<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: